Compounds > 1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide
Page last updated: 2024-11-12

1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11048104
CHEMBL ID3184506
SCHEMBL ID179865
MeSH IDM0585873

Synonyms (53)

Synonym
1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide, >=98.0% (t)
1-butyl-1-methylpyrrolidinium bis(trifluoromethanesulfonyl)imide
B2851
223437-11-4
1-butyl-1-methylpyrrolidinium bis(trifluoromethanesulfonyl)amide
nsc-747131
nsc747131
1-butyl-1-methyl pyrrollidinium bis(trifluoromethylsulfonyl)imide
NCGC00248984-01
dtxsid9047968 ,
NCGC00258635-01
tox21_201083
dtxcid9027944
cas-223437-11-4
AKOS015903348
1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide
SCHEMBL179865
n-butyl-n-methylpyrrolidinium bis((trifluoromethyl)sulfonyl)imide
Q-102717
1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide, >99%, <500 ppm h2o
CHEMBL3184506
1-n-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide
mfcd07784447
1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide, for electrochemistry, >=98.5% (t)
AS-71533
n-butyl-n-methylpyrrolidinium bistriflimide
1-butyl-1-methylpyrrolidinium bistriflimide
FD74DKK1WH ,
n-methyl-n-butylpyrrolidinium bis(trifluoromethylsulfonyl)imide
pyrrolidinium, 1-butyl-1-methyl-, salt with 1,1,1-trifluoro-n-((trifluoromethyl)sulfonyl)methanesulfonamide (1:1)
n-methyl-n-butyl-pyrrolidinium bis(trifluoromethanesulfonyl)imide
1-butyl-1-methylpyrrolidinium bis(trifluorome-thanesulfonyl) imide
1-butyl-1-methylpyrrolidin-1-ium bis((trifluoromethyl)sulfonyl)amide
Q27894431
n-butyl-n-methylpyrrolidinium bis((trifluoromethyl)sulfonyl)imide pound pyr14tfsi pound(c)
n-butyl,methylpyrrolidinium bis((trifluoromethyl)sulfonyl)imide
unii-fd74dkk1wh
nsc 747131
bis(trifluoromethylsulfonyl)azanide;1-butyl-1-methylpyrrolidin-1-ium
1-butyl-1-methylpyrrolidin-1-ium; trifluoro[(trifluoromethanesulfonylazanidyl)sulfonyl]methane
n-butyl-n-methylpyrrolidinium bis((trifluoromethyl)sulfonyl)amide
D88969
n-butyl-n-methylpyrrolidiniumbis((trifluoromethyl)sulfonyl)imide
SY067066
1-butyl-1-methylpyrrolidin-1-ium bis[(trifluoromethyl)sulfonyl]amide
1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulphonyl)imide
1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)azanide
1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide p1,4ntf2
n-butyl, methylpyrrolidinium bis(trifluoromethylsulfonyl)imide
1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide,
CS-W011645
pyrrolidinium, 1-butyl-1-methyl-, salt with 1,1,1-trifluoro-n-[(trifluoromethyl)sulfonyl]methanesulfonamide (1:1)
bmp-bti
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency43.58540.000714.592883.7951AID1259392
retinoid X nuclear receptor alphaHomo sapiens (human)Potency19.15330.000817.505159.3239AID1159527; AID1159531
pregnane X nuclear receptorHomo sapiens (human)Potency69.07820.005428.02631,258.9301AID1346982
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency9.84300.023723.228263.5986AID743222
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency27.50050.000323.4451159.6830AID743065
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.57 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index36.02 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
pyridine
azine : An organonitrogen compound of general structure RCH=N-N=CHR or RR'C=N-N=CRR'.		2.0810azaarene;
mancude organic heteromonocyclic parent;
monocyclic heteroarene;
pyridines		environmental contaminant;
NMR chemical shift reference compound
acetonitrile
acetonitrile: RN given refers to unlabeled cpd. acetonitrile : A nitrile that is hydrogen cyanide in which the hydrogen has been replaced by a methyl group.		2.0810aliphatic nitrile;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
NMR chemical shift reference compound;
polar aprotic solvent
dimethyl sulfate
dimethyl sulfate: RN given refers to unlabeled cpd; structure. dimethyl sulfate : The dimethyl ester of sulfuric acid.		2.0810alkyl sulfatealkylating agent;
immunosuppressive agent
thiazoles
[no description available]		2.08101,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
thioflavin t
thioflavin T: RN given refers to chloride; structure. thioflavine T : An organic chloride salt having 2-[4-(dimethylamino)phenyl]-3,6-dimethyl-1,3-benzothiazol-3-ium as the counterion. It is widely used to visualise and quantify the presence of amyloids, both in vitro and in vivo.		2.0810organic chloride saltfluorochrome;
geroprotector;
histological dye
trioctylmethylammonium
trioctylmethylammonium: used in high performance liquid chromatography for the separation of tRNA; RN given refers to chloride. methyltrioctylammonium : A quaternary ammonium ion with three octyl groups and one methyl group attached to the nitrogen.		2.0810quaternary ammonium ion
ConditionIndicatedRelationship StrengthStudiesTrials
Fungal Diseases
[description not available]		02.2510
Mycoses
Diseases caused by FUNGI.		02.2510